You have full access to this open access article. Its main goals are to control symptoms and ascites. For this experimental procedure, treatment efficacy and patient safety need to be closely monitored.
We performed a prospective registry study for patients with PSMs. Cisplatin C 7. Between November and June , we recorded data from patients and scheduled procedures. Tumor burden, patient fitness, quality of life, operating time and in-hospital stay remained stable over consecutive procedures. We recorded 21 non-access situations and 14 intraoperative complications 11 intestinal injuries, and three aspirations while inducing anesthesia.
Median overall survival was days interquartile range β Peritoneal cancer primarily occurs as mesothelioma or metastasis of mainly gastrointestinal or gynecologic primary tumors Henderson et al. Its diagnosis is associated with a worse prognosis than metastases from other locations Franko et al. The standard therapy depends on the therapeutic intention.
The treatment decision depends on the peritoneal cancer index PCI according to Sugarbaker Harmon and Sugarbaker ; Jacquet and Sugarbaker , primary tumor spread, histological entity and classification, lymphatic and distant metastases, patient's symptom burden, age, and comorbidities.
The indication is a palliative therapeutic strategy aiming to alleviate symptoms and ascites. Before this, a curative therapeutic option on the one hand and distant metastases on the other hand must be ruled out.
